• SENSEX 81,583.30
    -212.85 (--0.26%)
  • BANKNIFTY 55,714.15
    -230.75 (--0.41%)
  • Vishal Mega Mart
    129.95 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 109.09(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,129.90 1,679.10(%)
  • Tata Motors
    672.00 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bliss GVS Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 79.0
  • ISIN : INE416D01022
141.84 -5 (-3.54%)
  • As on 17 Jun 2025 (EOD)

  • Today’s Low

    140.83

  • Today’s High

    148.00

  • Open

    147.00

  • Perv Close

    147.05

  • 52W Low

    101.01

  • 52W High

    185.50

Key Indicators

  • P/E(TTM)

    21.67

  • Mar.Cap (₹Cr.)

    1,494.57

  • Div & Yield %

    0.35

  • Book Value(₹)

    100.47

  • Debt-Equity Ratio

    -3.54

  • AGM Date

    17-Jun-2025

  • EPS

    6.55

  • P/E Ratio

    21.67

Financials Ratios

  • Debt-Equity Ratio

    0.11

  • Mar.Cap (₹Cr.)

    1,494.57

  • RONW (%)

    11.02

  • ROCE (%)

    14.84

Score Board

  • Equity (₹ in Cr.)

    10.54

  • BV (₹)

    100.50

  • Sales( ₹ in Cr.)

    667.20

  • NP (in Cr.)

    68.97

  • NP Var(%)

    -9.0

  • Div%

    50.0

  • CPS (₹)

    9.10

  • EPS (₹)

    6.50

  • Traded Value (₹ in Lakhs)

    1,552.10

  • 52 Week High

    185.50

  • 52 Week Low

    101.01

  • Price BSE

    147.0

  • Price NSE

    147.00

  • Market Capital( in Cr.)

    1,552.10

  • P/C Ratio

    16.10

  • P/E Ratio

    22.50

  • Price Vs.BV

    6.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 605.46 598.34 636.36 465.51 441.95 426.59
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 605.46 598.34 636.36 465.51 441.95 426.59
Other Income 33.50 50.77 35.37 17.68 37.00 35.81
Stock Adjustments 6.36 -21.24 8.90 8.85 -2.37 3.68
Total Income 645.32 627.87 680.63 492.04 476.58 466.08
EXPENDITURE :            
Raw Materials 305.83 293.66 352.84 262.15 234.36 228.83
Power and Fuel Cost 8.81 5.80 7.09 6.99 4.70 3.57
Employee Cost 82.59 72.54 65.06 58.61 44.02 33.85
Other Manufacturing Expenses 17.25 11.57 11.54 7.49 6.23 6.49
Selling and Administration Expenses 66.73 66.90 67.07 36.90 36.23 43.93
Miscellaneous Expenses 64.52 36.48 32.45 10.76 13.88 20.51
Employee Benefit Expenses 82.59 72.54 65.06 58.61 44.02 33.85
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 545.74 486.95 536.05 382.90 339.42 337.17
Operating Profit 99.59 140.93 144.57 109.14 137.16 128.91
Interest 5.81 10.06 4.32 4.19 6.62 3.15
Gross Profit 93.78 130.87 140.25 104.95 130.54 125.76
Depreciation 23.52 15.17 13.85 13.76 8.83 5.75
Profit Before Tax 70.26 115.70 126.40 91.19 121.71 120.01
Current Tax 26.34 34.42 31.92 21.52 31.81 45.44
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -6.72 -4.21 1.81 2.16 -2.44 0.14
Reported Net Profit 50.64 85.48 92.66 67.50 92.33 74.43
Extraordinary Items -25.47 0.26 2.09 -0.02 0.53 -1.47
Adjusted Net Profit 76.11 85.22 90.57 67.52 91.80 75.90
Adjustment below Net Profit -0.15 -0.67 0.30 0.52 -0.26 -0.17
P & L Balance brought forward 846.18 765.33 676.22 613.36 533.69 471.84
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 4.10 3.97 3.86 5.16 12.41 12.41
P & L Balance carried down 892.57 846.18 765.33 676.22 613.36 533.69
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 50.00 50.00 50.00 50.00 100.00
Dividend Per Share(Rs) 0.50 0.50 0.50 0.50 0.50 1.00
Earnings Per Share-Unit Curr 4.84 8.21 8.94 6.54 8.95 7.22
Earnings Per Share(Adj)-Unit Curr 4.84 8.21 8.94 6.54 8.95 7.22
Book Value 94.41 89.96 82.12 73.26 66.21 58.49
Book Value(Adj)-Unit Curr 94.41 89.96 82.12 73.26 66.21 58.49

Shareholding Pattern

  • Promoter Group

    35.29%

  • Public Share Holding

    64.71%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 37,187,174 35.29 37,187,174 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 37,187,174 35.29 37,187,174 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 13,887,912 13.18 13,887,912 42
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6,901,355 6.55 6,901,355 1
Mutual Funds / UTI 2,374 0.00 2,374 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 20,791,641 19.73 20,791,641 45
2] Non Institution
Bodies Corporate 7,532,767 7.15 7,488,327 208
Clearing Members 29,841 0.03 29,841 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,368,559 1.30 1,279,199 832
Foreign Non Institution Other 200 0.00 200 1
Hindu Undivided Families 1,234,589 1.17 1,234,589 867
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,813,680 9.31 9,813,680 6
Individuals holding nominal share capital up to Rs. 1 lakh 24,573,678 23.32 23,328,826 47,524
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2,609,357 2.48 2,609,357 3
Sub Total 47,391,457 44.98 46,012,805 49,465
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 105,370,272 100.00 103,991,620 49,517

Company Background

Bliss GVS Pharma LtdPharmaceuticals - Indian - Formulations

  • Bliss GVS Pharma Ltd
  • BSE Code : 79.0
  • ISIN : INE416D01022

  • Incorporation Year

    1984

  • Registered Office

    102 Hyde Park Sakivihar Road
    Andheri East, Mumbai,
    Maharashtra-400072

  • Telephone

    91-22-42160000

  • FAX

    91-22-28563930

  • Chairman

    Nandkumar Kashinath Chodankar

  • Managing Director

    Gagan Harsh Sharmma

  • Company Secretary

    Aditi Bhatt

  • Auditor

    Kalyaniwalla & Mistry LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Universal Capital Sec. Pvt Ltd
    21 Shakil Niwas,
    Mahakali Caves Road,Andheri (E)
    Mumbai - Mumbai - 400 093

Bliss GVS Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bliss GVS Pharma 141.95 638.96 605.46 21.67 11.19
Abbott India 31,803.35 6,097.18 5,848.91 47.78 44.71
Astrazeneca Phar 10,081.60 1,330.33 1,295.53 217.75 33.26
P & G Health Ltd 5,907.05 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,252.30 3,866.05 3,723.49 59.95 58.72
Cipla 1,503.50 17,645.00 16,574.34 23.54 20.10
Novartis India 1,005.10 396.75 335.07 24.59 15.57
Amrutanjan Healt 708.25 437.58 421.23 40.29 20.84
Guj. Themis Bio. 337.05 174.19 169.82 75.23 44.82
Fermenta Biotec. 334.25 315.24 307.09 14.55 4.10
Ambalal Sarabhai 36.76 11.70 3.81 34.04 1.92